Darius Kharabi
Corporate Officer/Principal presso KALA BIO, INC.
Patrimonio netto: 100 807 $ in data 31/05/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Mark Blumenkranz | M | 73 |
Combangio, Inc.
 Combangio, Inc. Miscellaneous Commercial ServicesCommercial Services Combangio, Inc. operates as an investment holding company. The company was headquartered in Menlo Park, CA.
Lagunita Biosciences LLC
 Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | 10 anni |
| Mark Iwicki | M | 57 | 9 anni | |
| Howard Rosen | M | 66 | 10 anni | |
| Mary Reumuth | F | 48 | 10 anni | |
| Eric Trachtenberg | M | 51 | 6 anni | |
| Marjan Farid | M | 50 | 2 anni | |
| Todd Bazemore | M | 53 | 7 anni | |
| Gregory Perry | M | 63 | 6 anni | |
| Andrew Koven | M | 66 | 7 anni | |
| Yehuda Ivri | M | 72 |
Kedalion Therapeutics, Inc.
 Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | - |
| Charles Myers | M | 70 | 3 anni | |
| Dana Mead | M | 64 |
Kedalion Therapeutics, Inc.
Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | - |
| Paul Wachter | M | 67 |
Lagunita Biosciences LLC
Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | - |
| Thomas Krummel | M | 72 |
Lagunita Biosciences LLC
Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | 9 anni |
| Daniel Palanker | M | - |
Lagunita Biosciences LLC
Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | - |
| David Myung | M | - |
Lagunita Biosciences LLC
Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | - |
| Heath Lukatch | M | 56 |
Lagunita Biosciences LLC
Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | - |
| John S. Power | M | - |
Kedalion Therapeutics, Inc.
Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | - |
| Marc Gleeson | M | - |
Kedalion Therapeutics, Inc.
Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | 5 anni |
| Hannah Deresiewicz | F | - | - | |
| Romulus Brazzell | M | 71 | 11 anni | |
| Casey Dougan | M | - |
Kedalion Therapeutics, Inc.
Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | 5 anni |
| Christine Banian | F | - |
Lagunita Biosciences LLC
Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Robert Paull | M | 47 | - | |
| Gregory Grunberg | M | 51 | 7 anni | |
| Susan L. Coultas | M | - | 6 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 26 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Darius Kharabi
- Contatti personali
